 |
Recombinant human highly phosphorylated acid alpha-glucosidase |
|---|---|
| Trade Name | Tbd |
| Orphan Indication | Pompe disease |
| USA Market Approval | USA |
| USA Designation Date | 2000-09-20 00:00:00 |
| Sponsor | Novazyme Pharmaceuticals, Inc.;800 Research Parkway, Suite 200;Oklahoma City, Oklahoma, 73104 |
